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Background: Prompt access to artemesinin-combination therapy (ACT) is not adequate unless the drug is taken
according to treatment guidelines. Adherence to the treatment schedule is important to preserve efficacy of the
drug. Although some community based studies have reported fairly high levels of adherence, data on factors
influencing adherence to artemether-lumefantrine (AL) treatment schedule remain inadequate. This study was
carried-out to explore the provider’s instructions to caretakers, caretakers’ understanding of the instructions and
how that understanding was likely to influence their practice with regard to adhering to AL treatment schedule.
Methods: A qualitative study was conducted in five villages in Kilosa district, Tanzania. In-depth interviews were
held with providers that included prescribers and dispensers; and caretakers whose children had just received AL
treatment. Information was collected on providers’ instructions to caretakers regarding dose timing and how to
administer AL; and caretakers’ understanding of providers’ instructions.
Results: Mismatch was found on providers’ instructions as regards to dose timing. Some providers’ (dogmatists)
instructions were based on strict hourly schedule (conventional) which was likely to lead to administering some
doses in awkward hours and completing treatment several hours before the scheduled time. Other providers
(pragmatists) based their instruction on the existing circumstances (contextual) which was likely to lead to delays in
administering the initial dose with serious treatment outcomes. Findings suggest that, the national treatment
guidelines do not provide explicit information on how to address the various scenarios found in the field. A
communication gap was also noted in which some important instructions on how to administer the doses were
sometimes not provided or were given with false reasons.
Conclusions: There is need for a review of the national malaria treatment guidelines to address local context. In
the review, emphasis should be put on on-the-job training to address practical problems faced by providers in the
course of their work. Further research is needed to determine the implication of completing AL treatment prior to
scheduled time.
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Plasmodium falciparum malaria continues to be a public
health problem in sub-Saharan Africa [1,2]. About
800,000 people die of malaria each year, 85% of them
under the age of five [2]. Case management is the main
strategy for the control of malaria, aiming to eliminate
malaria related deaths by 2015. Reduction of the death
rate depends on successful malaria case management
through early provision of drugs that are efficacious,
safe, prescribed and taken in the right doses and ad-
equate duration [3].
The last decade has seen many African countries
changing their drug policies to implement artemisinin-
based combination therapy (ACT) [2]. Tanzania Main-
land, changed its drug policy from Sulfadoxine-
pyrimethamine (SP) to the highly efficacious ACT in
2006 [4]. One of the major barriers to the successful
treatment of malaria is non-adherence to treatment
schedule, as most treatments are taken at home without
medical supervision [5,6]. Non-adherence to treatment
schedule might result in treatment failure, increase mor-
tality and/or drug resistance [7]. Besides, it will take sev-
eral years before a new drug comes into the market.
There is therefore a need to preserve efficacy of the
existing ACT.
In the efficacy and safety study on artemether-
lumefantrine (AL) use in children, the co-artemether
six-dose schedule, treating acute uncomplicated falcip-
arum malaria achieved rapid parasite clearance and a
high cure rate[8]. In adherence study, the majority of
children were reported to have received all doses. Cases
of non-adherence were due to lack of timely dosing ra-
ther than missing doses [9]. Additionally, the recent
community based studies reported fairly high levels of
adherence to ACTs in Tanzania Mainland (90%) and
Zanzibar (77%) [10,11]. Despite the small percentage of
non-adherence, there is still need to address the problem
of non-adherence for fear of building up drug pressure
that might, with time, lead to drug resistance. Already
there is a threat of parasite resistance to artemisinin in
South-East Asia [12]. Moreover, community-based stud-
ies using caretakers’ report and pill count to estimate ad-
herence to treatment, suggests likely overestimation of
adherence due to recall bias and social desirability re-
sponse [13-15]. Thus, in reality, the actual level of non-
adherence might be higher than reported.
Some of the factors reported to influence adherence to
antimalarial treatment include level of basic education,
forgetfulness and receiving the first dose at the health fa-
cilities [6,10,11,16-18]. While only a few of these studies
were conducted after the policy change to ACT in Africa
[10,11], we lack qualitative data that would provide in-
depth understanding of the interrelationship between
the various factors explaining non-adherence [19]. Thisqualitative study was carried out to fill this gap by ex-
ploring the providers’ instructions to caretakers, care-
takers’ understanding of the instructions and how that
understanding was likely to influence their practice with
regard to adhering to AL treatment schedule.
Methods
Design of the study
This study used qualitative methods of data collection,
strategically, due to its inquiry paradigm [20,21] as it
enabled the researchers to understand the context
related to prescription, dispensing and administration of
AL to children under-five years of age. The study was
conducted one year after the completion of a quantita-
tive study conducted in the same area, which reported a
relatively high rate of adherence to treatment schedule
[9]. Among cases of non-adherence, non-adherence was
found to be associated with untimely dosing (off-sched-
ule dosing) rather than missing doses.
The setting
The study was conducted in three rural and two semi-
urban villages in Kilosa district in May 2010. Purposive
selection was done based on villages involved in the
quantitative study. In Kilosa district, malaria accounts
for more than half of patients attending the outpatient
department and 60% of deaths among children under-
five years of age admitted in the hospitals [District an-
nual report, 2008]. The district has 71 health facilities; of
these, only the 3 hospitals and 7 health centres have
microscopes for malaria diagnosis. A dispensary is usu-
ally run by a clinician and a public health nurse and
serves about 10,000 people. Health centres which,
ideally, were designed to serve as referral facilities for
dispensaries have about 4–7 clinicians and cater for
about 50,000 people.
Study participants and sampling procedures
Study subjects were prescribers and dispensers from one
faith-based hospital, two government health centres and
two government dispensaries. Dispensers from five drug
shops were also involved. Dispensers and prescribers who
were on duty on the day of the study were selected and
interviewed. As such, all prescribers in the district had
been trained on the new treatment guidelines prior to the
introduction of AL. In each facility, caretakers reporting
to have children under-five years of age, diagnosed to have
malaria and treated with AL; were purposively selected to
participate in the study, until information saturation was
achieved.
A total of 22 interviews were conducted. The sample
of interviewees involved eight prescribers comprised of
two Assistant Medical Officers (AMOs) and five Clinical
Officers (COs). Three prescribers were females and five
Table 1 The pattern of treatment schedules given to
caretakers by providers on the administration of
artemisinin-lumefantrine to children
Scenarios Time in 24 hours
1st dose 2nd dose 3rd dose 4th dose 5th dose 6th dose
1 0600 1400 0600 1800 0600 1800
2 1600 2200 0600 1800 0600 1800
3 1600 2200 1600 0400 1600 0200
4 2200 0600 1800 0600 1800 0600
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dispensers who had been trained on dispensing practice
were also involved. Four drug dispensers from drug
shops were interviewed; three females and one male. A
total of eight caretakers were interviewed during exit
interviews; five females and three males. Age of provi-
ders and dispensers ranged from 32 to 54 years and age
of caretakers ranged from 20 to 39 years.
Data collection
Individual in-depth interviews (IDI) were semi-
structured. Use of semi-structured interviews enabled
interviewers to ask key questions and probe on different
aspects related to the study [21-23]. An interview guide
[24] was developed and used to ensure coverage of simi-
lar topics with all informants; making interviews system-
atic, comprehensive and focused [20]. Interview
questions for providers focused on availability of anti-
malarial drugs in general and AL specifically; and in-
struction they provided to caretakers on dose timing;
how to administer the drugs in relation to food and what
to be done in case the child vomits. Caretakers were
interviewed about their preference on antimalarial drugs
and their understanding of provider’s instructions. Care-
takers were also interviewed about child’s symptoms
prior to seeking health care.
The interviews were conducted in Kiswahili, language
widely spoken in Tanzania. While the caretakers were
interviewed immediately as they exited the services, pro-
viders were interviewed in their offices during the after-
noon breaks and after working hours. While interviews
with clinicians ranged between one to two hours, inter-
views with dispensers took about half to one hour. Simi-
larly, interviews with caretakers ranged between half to
one hour. Interviews were conducted by one of the
authors (DK) while the other (DS) took notes [25]. Two
interviews were conducted in a day, one in the morning
and another in the afternoon. Discussions were held in
the evening to reflect on findings and to deliberate on
the probes for the next day. Interviews were recorded
after obtaining interviewee’s consent. None of the inter-
viewees refused to be recorded.
Data processing and analysis
All recorded interviews were transcribed by the
researchers immediately after completion of the field
work. Transcripts were thereafter translated from Kiswa-
hili, a language spoken by the interviewees as well as the
authors, to English. A quality check was conducted by
an independent researcher who confirmed that the inter-
views were accurately transcribed and translated. The
next step was data analysis. According to Bogdan and
Biklen [22], qualitative data analysis involves “working
with data, organizing it, breaking it into manageableunits, synthesizing it, searching for patterns, discovering
what is important and what is to be learned, and decid-
ing what you will tell others”. Accordingly, qualitative
content analysis of the data was conducted by reading
and re-reading of transcripts followed by data coding.
One of the investigators did the coding and then dis-
cussed with the second investigator before reaching a
consensus [25]. Coding was done manually by grouping
them according to categories which were then grouped
into subcategories.
Ethical considerations
Ethical clearance was sought and obtained from the In-
stitutional Review Board (IRB) of the Muhimbili Univer-
sity of Health and Allied Sciences (MUHAS). Research
permit was sought and obtained from the regional and
district authorities as well as from the in-charge of the
respective health facilities, prior to data collection. For
the prospective interviewees, a written consent was
sought and obtained. Each prospective participant was
informed about the objectives of the study and was told
that participation was voluntary. Participants were
assured that information collected would be for research
purposes only and confidential. Interviews were tape
recorded after seeking and obtaining permission from
the interviewees. Participants were informed that the
discussions would be recorded for the purpose of keep-
ing correct information. Participants were also informed
about their freedom not to be recorded and that the de-
cision was to be highly respected.
Results
Mismatch amongst providers on instructions given to
caretakers on dose timing
A mixture of consensus and inconsistencies were noted
among providers, on the way they communicated infor-
mation to caretakers. The dose schedule reported by the
providers who participated in the study was categorized
into four patterns as shown in Table 1.
There was a consensus among prescribers and drug
dispensers that the spacing between the first and the
second dose should be about 8–12 hours (Table 1, Sce-
nario 1). There seemed to be no problem in interpreting
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doses, when the first dose was administered early in the
morning. The instruction followed the conventional 0, 8,
24, 36, 48, 60 hourly schedule as well as the convenient
morning and evening schedule [4,26]. In this case, the
instructions were quite clear, as reported by one of the
providers:
“If I have seen the patient at eight in the morning, I
will tell the caretakers to give the second dose in the
afternoon at four, then the third dose at eight on the
next day in the morning, the fourth dose at eight in
the evening and on the third day to give the fifth dose
in the morning at eight and the sixth dose at eight”
(Provider, government facility).
There was, however, a mismatch among providers
when the first dose was administered in the afternoon.
Whereas, some providers reported advising caretakers to
administer the third dose at about 1600 hour so as to
coincide with the 24th hourly schedule, (Table 1, Sce-
nario 3), others advised caretakers to administer the
dose at about 0600 hours in the morning of the next day
so as to coincide with the convenient morning and even-
ing schedule (Table 1, Scenario 2).
Dogmatism in the interpretation of malaria treatment
guidelines
Providers who strictly followed the 0, 8, 24, 36, 48, 60
hourly schedule did so irrespective of the contextual fac-
tors at the health facilities and those related to the care-
takers. The national malaria treatment guidelines
recommend administering the first dose with food, at
the health facility [4,26]. Although most health facilities
lacked safe water for administering the drugs and most
of caretakers cannot afford buying food from vendors,
some providers reported to have instructed caretakers to
start the first dose at the health facility as a direct obser-
vation treatment, as one of dispensers reported:
“After reading the prescription, if AL is prescribed for
the child, I will instruct the caretaker to immediately
administer the drug while they are still at the health
facility and instruct her that the next dose should be
administered eight hours after the first dose”
(Provider, faith based organization facility).
The dogmatic position taken by some providers who
followed the hourly schedule led some providers to ad-
vice caretakers to administer some doses in the night.
This was reported to be cumbersome to administer es-
pecially to caretakers who had no cues to remind them.
When asked how they were able to keep time in the
night, caretakers reported staying awake until the appro-
priate time, arguing that:
“If the child is still sick, I cannot sleep. So I will stay
awake until the time for giving the drugs” (Caretaker,
government facility).Some of the strategies employed by caretakers to ad-
here to treatment schedule that fell in awkward hours
included the use of cell-phones alarm and radios
announcements. This was reported by caretakers in
semi-urban areas. Others reported to rely on Muslims
calls for prayers which are regularly made at 0500 hours,
1300 hours, 1600 hours, 1800 hours and 2000 hours. In
areas where there is electricity, mostly semi-urban, loud
speakers are used when making Muslims calls for
prayers and can be heard over a wide area.
Pragmatism in interpreting malaria treatment guidelines
Providers who followed the convenient schedule
instructed caretakers to administer subsequent doses in
the mornings and afternoons, basing their decisions on
practical considerations, in order to avoid administering
drug in the night. Due to difficulties in administering
drugs at night, some providers took a pragmatic position
by instructing caretakers to administer doses in the
morning and evening irrespective of the time the first
dose was administered. This statement was confirmed
by one of the caretakers who said:
“The health provider asked me when I was likely to
arrive at home and I said around 2.00 pm. He then
told me that, I should administer the drug after
feeding the child and continue with the subsequent
doses in the evenings and mornings until I finish all
the doses” (Caretaker, government facility).
When instructing this caretaker on when to start the
initial dose, the provider took into consideration the fact
that there was no safe water available at the facility for
administering the drugs and that most caretakers cannot
afford to buy food from vendors. In the effort to avoid
administering some doses in the night, some providers
(pragmatic) instructed caretakers to defer administering
the first dose until ten in the night and thereafter admin-
ister the subsequent doses at six in the morning and six
in the evening (Scenario 4, Table 1). One of the provi-
ders was quoted saying:
“. . . in order to make it easy for the mothers to follow
the timing, I normally advice those coming in the
afternoon to start the first dose at ten in the night so
that the following doses can be given at six in the
morning and six in the afternoon” (Provider,
government facility).
In making this decision, the provider sought to achieve
both hourly and convenient time schedules. The ten-
dency to defer administering the first dose was also con-
firmed by some of the caretakers.
Communication gaps
Communication gaps were characterised by inadequate
information to caretakers and misinformation. While
some providers reported advising caretakers to administer
Simba and Kakoko BMC Health Services Research 2012, 12:146 Page 5 of 8
http://www.biomedcentral.com/1472-6963/12/146AL just after or before feeding the child others did not
provide such advice. Of those who did, some did not pro-
vide specific information on the time interval between
feeding and drug administration. The national malaria
treatment guidelines recommend administering AL within
one hour of taking food. In addition, whereas some provi-
ders reported instructing caretakers to administer the
drug with food cooked with oil, others did not. This infor-
mation was confirmed by caretakers, who reported being
instructed to administer AL with food but denied receiv-
ing instructions that food should be cooked with oil.
Some providers reported to have instructed caretakers
to administer another dose if the child vomits within an
hour. For caretakers who could not estimate the time,
providers instructed them to re-administer the drug if
they see un-dissolved particles of the tablet in the vom-
itus. Although some providers reportedly instructed
caretakers to return for an additional tablet others gave
no specific instructions. Those advising caretakers to re-
turn did not give specific information on whether to re-
turn immediately or after finishing the last pill. When
providers were probed about their experiences with
caretakers reporting back for a replacement dose, none
of them reported such an encounter. Caretakers con-
firmed providers’ report regarding instruction for care-
takers to give another dose if the child vomits and
admitted to have not been told on how and when to
seek replacement.
There were providers’ who misinformed caretakers on
the reasons for taking AL with food. Explaining the rea-
sons, one of the providers said:
“They should not give the drugs on an empty stomach
because the drugs are very strong and will cause
stomach ache” [Provider, government facility]
Apparently, the reason for taking the drug with food is
to facilitate absorption.
Discussion
This study found a mismatch amongst providers on the
instructions given to caretakers on the use of AL for
treating uncomplicated malaria. In determining the time
for administering AL, some providers (dogmatists) based
their instructions on the number of hours from the first
dose, that is 0, 8, 24, 36, 48 and 60 hours. Others used
the more convenient time period schedule (pragmatists),
that is, morning and evenings. Both approaches are
recommended by the national treatment guidelines for
treating uncomplicated malaria as adopted from the
WHO [4,26]. The guidelines outline the dose schedule
in number of hours from the first dose as 8, 24, 36, 48
and 60. However, for ease of use, the guidelines recom-
mend that the second dose should be given on the first
day, any time between 8 hours and 12 hours after the
first dose and the dosage on the second and third daysshould be given twice a day in the morning and evening
[26]. Apparently, the two treatment approaches did not
lead to the same dose timing and when translated into
practice each had its own limitation. Table 2 summarises
practical implications of the instructions provided for
each category of providers.
Whereas, the dogmatic approach led some providers
to prescribe a cumbersome dosing schedule, with some
doses administered in the night, in the pragmatic ap-
proach some providers instructed caretakers on a timing
schedule that led to delay in the initiation of the first
dose. In addition, pragmatic approach resulted into the
reduction of the period between the first and the third
doses; and completing the last dose several hours before
the scheduled time.
The national treatment guidelines recommend adminis-
tering the first dose at the health facility and also adminis-
tering the doses with food. In this study, some of the
“pragmatic” providers reported instructing caretakers to
defer starting the first dose until they reach home, where
they could administer the drug using safe water after feed-
ing the child. Other pragmatic providers instructed care-
takers to start the first dose at 10.00 pm in the night so as
to match the subsequent doses with the convenient sched-
ule of mornings and evenings. Previous researchers
reported caretakers’ delays in recognizing symptoms and
seeking care from health facilities; long travelling and
waiting times [17,27] that puts children to a higher risk of
dying before reaching health facilities [28,29]. Therefore,
despite the advantages of the pragmatic approach, defer-
ring treatment is likely to further delay the initiation of
treatment, thus, exposing the sick child to a higher risk of
developing severe malaria, central nervous system compli-
cations and dying [30,31].
The pragmatic approach in which the third dose is
administered in the morning irrespective of the time the
first dose was taken would result in shortening the
period between first and the third doses and completing
the last dose before the scheduled time. Fortunately, AL
is reported to be safe, with a wide window of safety and
is well tolerated by patients [26,32]. In addition, taking
AL at incorrect duration has been reported to make no
difference on the treatment outcome [33]. However,
completing the last dose before the scheduled time
might expose parasites to lower drug concentration in
blood with a risk of drug resistance [32].
This study reported that, some providers strictly fol-
lowed the hourly schedule (dogmatic) when prescribing
AL. This was likely to result into cumbersome dosing
where some doses were supposed to be administered in
the night. In the efforts to militate against the awkward
timing, some of the caretakers reported to have stayed
awake until such time. However, this is possible when
the child looks ill because a sick child tends to draw
Table 2 Category, practical implications, and consequences of providers’ instructions
Category Practical implications Negative consequence
Dogmatic (conventional) Giving 1st dose at the health facility •Takes first dose on empty stomach
•No assurance of safe water to take the dose at the facility
Following the 0, 8, 24, 36, 48, 60 hourly schedule •Midnight doses
•Difficult where people have no reminders
Pragmatic (contextual) Starting first dose when caretakers reach home Delay in starting treatment
Giving 3rd and subsequent doses in the morning 1200 am and
evening 1200 pm regardless of when the first dose was given
•Shortening the period between 1st and 3rd dose
•Completing treatment several hours prior scheduled time
Defer administering first dose until night time 10.00 pm so
that the 3rd and subsequent doses would be given in
the morning 12.00 am and evening 12.00 pm
Delay in starting treatment
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parasitaemia and symptoms within 24 hours of taking
the first dose [32]. Thus, caretakers are likely to be less
vigilant in the second and third days when the child
condition is seen to have improved and has started play-
ing [11,34]. The complacency might contribute to non-
adherence to AL treatment schedule [10,11].
The mismatch among providers on the instructions
given to caretakers could be explained by the failure to
adapt and translate the WHO treatment guidelines into
the national treatment guidelines. Instead of taking into
consideration the different local scenarios the national
treatment guidelines adopted a one-size-fits-all recom-
mendation. Thus, the mismatch could be argued to be a
result of providers’ efforts to offer caretakers the best
option that suits the practical situation pertaining in the
field. The mismatch might also be explained by inad-
equate providers’ training since only one round off train-
ing was conducted during the introduction of AL
(personal communication with the DMO). Inadequate
supervision and continuing professional education
among providers has been reported in the country and
elsewhere [35-37]. These factors might also have com-
promised providers’ opportunity to seek and obtain
clarification when faced with practical challenges in the
course of implementing the treatment guidelines. This
underscores the need for reinforcing mechanisms to sus-
tain change in providers’ behaviour since a one-off train-
ing program is not sufficient [38].
The national malaria treatment guidelines recommend
taking AL tablets with milk or fat-containing food, par-
ticularly on the second and third days of treatment so as
to increase absorption of lumefantrine [26,39]. This
study found that some important information was not
always given to caretakers, and when given, it was some-
times provided with false reasons. This finding provides
an explanation to a previous research finding that
reported a majority of caretakers administered AL to
their children without food [11]. Administering AL with
food is advisable because of the influence of lumefantrineexposure on clinical and parasitological outcomes [40].
Therefore, providers should be trained to provide correct
information on the importance of administering AL with
food and or oil.
The national treatment guidelines also recommend
administering a replacement dose to a child who vomits
within half an hour [26,39]. In this study, some providers
reported to have advised caretakers to administer an-
other dose if the child vomits the drug. However, none
of them explained the need for, and when to come back
for a replacement dose. Inadequate information on what
caretakers should do if the child vomits have also been
reported in other studies [11,41]. A study conducted in
Kilombero, Tanzania, reported that nearly half of the
caretakers believed that a replacement dose could be
taken from the existing blister pack while some of them
were of the opinion that no further action was required
[11]. Since vomiting is one of the commonest malaria
symptoms, it is probable that a large number of sick
children vomited the drug without getting a replace-
ment. This is likely to result in under dosing the child
hence poor treatment outcome. While it is important to
ensure adequate provider training and follow up, further
research is needed to determine the proportion of chil-
dren who vomits the drug without getting a replacement
dose and the effect it has on parasite clearance and
treatment outcome.
Overall, this study reports a mismatch amongst provi-
ders on the instructions they gave to caretakers regard-
ing dose timing; and incomplete and misinformation on
how to administer AL. As past adherence behaviour is
known to be a strong predictor of future behaviour [42],
adherence to AL is likely to improve if providers present
consistent information and ensure that caretakers get
opportunity to internalize the instructions [43]. This
study, therefore, adds knowledge regarding some of the
provider-caretaker communication challenges likely to
contribute to caretakers’ non-adherence to AL treatment
schedule [5] and to providers adherence to treatment
guidelines in general [36,41,44,45].
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have to be noted. The validity of research finding is of
major concern in qualitative studies [46]. In this study,
we tried to address this through interviewers’ triangula-
tion where we interviewed providers, dispensers and
caretakers separately, and in most cases obtained similar
findings. In addition, in the attempt to achieve research-
ers’ triangulation [25] data analysis was done by a public
health specialist [25] with medical background and an-
other with social sciences background [19,47].
Consistency in the findings was ensured through tape-
recording of the interviews, coding and categorization
which was done by one of the authors and counter-
checked by the second author. Responses from the initial
interviewees were reflected in the subsequent interviews
through probing, as a method of getting feedback, thus,
ensuring consistency. Finally, we did not follow up care-
takers at their homes to determine if the instructions
that they reported to have been given were translated
into action. Nonetheless, the fact that the mismatch
among providers was confirmed by caretakers shows
that this pattern is also likely to be reflected in practice.
Conclusions
This study reports a mismatch amongst providers’
instructions to caretakers on when and how to adminis-
ter AL to children suspected to have malaria. There were
providers who gave conventional instructions (dogmatic)
that were likely to contribute to cumbersome dosing and
ultimately to non-adherence to treatment schedule.
There were also providers who provided instructions
based on context (pragmatic). Despite the advantage of
pragmatic approach, deferring the initiation of treatment
exposes children to a higher risk of developing severe
malaria and ultimately complications and or deaths. In-
adequate and misleading information by some providers
on administering AL with food and the action to take if
the child vomits the drug is also likely to compromise
treatment outcome and create a potential for drug
resistance.
While there is need for a review of the national mal-
aria treatment guidelines to address local context, em-
phasis should be put on on-the-job training to address
practical problems faced by providers in the course of
their work. Further research is needed to determine the
implication of completing AL treatment prior to sched-
uled time.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
Thanks to the Muhimbili University of Health and Allied Sciences (MUHAS)/
and Karolinska Institutet (KI) Malaria collaboration project for supporting the
research. We thank all participants, research assistants and others involved in
conducting this study.Author details
1Department of Community Health, Muhimbili University of Health and
Allied Sciences, Dar es Salaam, Tanzania. 2Department of Behavioural
Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam,
Tanzania.Authors’ contributions
DS and DK took part in designing the study, tools development, data
analysis and manuscript writing. They both were involved in the field work.
All authors approved the final manuscript.
Received: 30 August 2011 Accepted: 8 June 2012
Published: 8 June 2012References
1. Lusingu J, Vestergaard L, Mmbando B, Drakeley C, Jones C, Akida J, Savaeli
Z, Kitua A, Lemnge M, Theander T: Malaria morbidity and immunity
among residents of villages with different Plasmodium falciparum
transmission intensity in North-Eastern Tanzania. Malar J 2004, 3(26).
doi:10.1186/1475-2875-3-26.
2. WHO: World Malaria Report. Geneva: World Health Organization; 2009:13.
3. Roll-Back-Malaria-Partnership: Global strategic plan Roll Back Malaria 2005–
2015.: Roll Back Malaria Partnership; 2005.
4. MoH&SW: National Guidelines for Malaria Diagnosis and Treatment 2006.
Tanzania: Ministry of Health and Social Welfare; 2006.
5. Conteh L, Stevens W, Wiseman V: The role of communication between
clients and health care providers: implications for adherence to malaria
treatment in rural Gambia. Trop Med Int Health 2007, 12(3):382–391.
6. Yeung S, White N: How do patients use antimalarial drugs? A review of
the evidence. Trop Med Int Health 2005, 10(2):121–138.
7. White N: Why is it that antimalarial drug treatments do not always work?
Ann Trop Med Parasitol 1998, 92(4):367–391.
8. Falade C, Makanga M, Premji Z, Ortmann C, Stockmeyer M, Ibarra de
Palacios P: Efficacy and safety of artemether-lumefantrine (CoartemW)
tablets (six-dose regimen) in African infants and children with acute,
uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 2005, 99
(48):459–467.
9. Simba D, Kakoko D, Tomson G, Premji Z, Petzold M, Mahindi M, Gustafsson
L: Adherence to artemether/lumefantrine treatment in children under
real-life situations in rural Tanzania. Trans R Soc Trop Med Hyg 2012,
106:3–9.
10. Beer N, Ali A, Rotllant G, Abass A, Omari R, Al-mafazy A, Bjo¨rkman A,
Ka¨llander K: Adherence to artesunate–amodiaquine combination therapy
for uncomplicated malaria in children in Zanzibar, Tanzania. Trop Med Int
Health 2009, 14(7):766–774.
11. Kabanywanyi A, Lengeler C, Kasim P, King’eng’ena S, Schlienger R, Mulure N,
Genton B: Adherence to and acceptability of artemether-lumefantrine as
first-line anti-malarial treatment: evidence from a rural community in
Tanzania. Malar J 2010, 9(48). doi:10.1186/1475-2875-1189-1148.
12. Wongsrichanalai C, Sirichaisinthop J, Karwacki J, Congpuong K, Miller R,
Pang L, Thimasarn K: Drug resistant malaria on the Thai-Myanmar and
Thai-Cambodian borders. Southeast Asian J Trop Med Public Health 2001,
32(1):41–49.
13. Bell D, Wootton D, Mukaka M, Montgomery J: Measurement of adherence,
drug concentrations and the effectiveness of artemether-lumefantrine,
chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the
treatment of uncomplicated malaria in Malawi. Malar J 2009, 8(204).
doi:10.1186/1475-2875-1188-1204.
14. Choo P, Rand C, Inui T, Lee M, Cain E, Cordeiro-Breault M, Canning C, Platt
R: Validation of Patient Reports, Automated Pharmacy Records, and Pill
Counts With Electronic Monitoring of Adherence to Antihypertensive
Therapy. Med Care 1999, 37(9):846–857.
15. Ruslami R, van Crevel R, van de Berge E, Alisjahbana B, Aarnoutse R: A step-
wise approach to find a valid and feasible method to detect non-
adherence to tuberculosis drugs. Southeast Asian J Trop Med Public Health
2008, 39(6):1083–1087.
16. Chinbuah A, Gyapong J, Pagnoni F, Wellington E, Gyapong M: Feasibility
and acceptability of the use of artemether-lumefantrine in the home
management of uncomplicated malaria in children 6–59 months old in
Ghana. Trop Med Int Health 2006, 11(7):1003–1016.
Simba and Kakoko BMC Health Services Research 2012, 12:146 Page 8 of 8
http://www.biomedcentral.com/1472-6963/12/14617. Nsungwa-Sabiiti J, Tomson G, Pariyo G, Ogwal-Okeng J, Peterson S:
Community effectiveness of malaria treatment in Uganda - a long way
to Abuja targets. Ann Trop Paediatr 2005, 25:89–98.
18. Piola P, Fagg C, Bajumirwe F, Biraro S, Grandesso F: Supervised versus
unsupervised intake of six-dose artemether-lumefanthrine for treatment
of acute, uncomplicated Plasmodium falciparum malaria in Mbarara,
Uganda: a randomized trial. Lancet 2005, 365:1467–1473.
19. Cresswell J: Qualitative inquiry and research design: choosing among five
approaches. 2nd edition. California: Sage; 2007.
20. Hoepfl C: Choosing Qualitative Research: A Primer for Technology
Education Researchers. J Technol Educ 1997, 9(1):47–63.
21. Kvåle S: Interviews: An introduction to qualitative research interviewing.
California: Thousand oaks, Sage; 1996.
22. Bogdan R, Biklen S: Qualitative research for education: An introduction to
theory and methods. Boston: Allyn and Bacon, Inc; 1982.
23. Denscombe M: The good research guide for small -scale social research
projects. Buckingham: Open University Press; 1998.
24. Patton MQ: Qualitative Evaluation and Research Methods. 2nd edition.
Newbury Park, CA: Sage Publications, Inc; 1990.
25. George M, Tovia G, Freedman D, Norfleet A, Feldman H, Apter A:
Qualitative research-enhanced understanding of patients’ beliefs: Results
of focus groups with lowincome, urban, African American adults with
asthma. J Allergy Clin Immunol 2003, 111:967–973.
26. WHO: Guidelines for the Treatment of Malaria. Geneva: World Health
Organisation; 2006.
27. Rutebemberwa E, Kallander K, Tomson G, Peterson S, Pariyo G:
Determinants of delay in care-seeking for febrile children in eastern
Uganda. Trop Med Int Health 2009, 14(4):472–479.
28. McCombie S: Treatment seeking for malaria - a review of recent
research. Soc Sci Med 1996, 43:933–945.
29. WHO: Improving access to antimalarial medicines. Report of the RBM
Partnership meeting. Geneva: World Health Organization; 2003.
30. de Savigny D, Mayombana C, Mwageni E, Masanja H, Minhaj A, Mkilindi Y,
Mbuya C, Kasale H, Reid G: Care-seeking patterns for fatal malaria in
Tanzania. Malar J 2004, 3(27).
31. Gomes M, Faiz M, Gyapong J, Warsame M, Agbenyega T, Babiker A, et al:
Pre-referral rectal artesunate to prevent death and disability in severe
malaria: a placebo-controlled trial. Lancet 2009, 373(9663):557–566. 14.
32. White N: Antimalarial drug resistance. J Clin Inv 2004, 113:1084–1092.
33. Sirima S, Konate A, Tiono A, Convelbo N, Cousens S, Pagnoni F: Early
treatment of childhood fevers with pre-packaged antimalarial drugs in
the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int
Health 2003, 8(2):133–139.
34. Simba D, Kakoko D, Warsame M, Premji Z, Gomes M, Tomson G, Johansson
E: Understanding caretakers’ dilemma in deciding whether or not to
adhere with referral advice after pre-referral treatment with rectal
artesunate. Malar J 2012, 106:3–9.
35. MoH&SW: Joint External Evakuation: The health sector in Tanzania, 1999–
2006.: Ministry of health and Social Welfare; 2007.
36. Rowe A, De-Savigny D, Lanata C, Victoria C: How can we achieve and
maintain high-quality performance of health workers in low-resource
settings? Lancet 2005, 366:1026–1035.
37. Travis P, Bennett S, Haines A, Pang T, Bhutta Z, Hyder A, Pielemeier N, Mills
A, Evans T: Overcoming health-systems constraints to achieve the
Millennium Development Goals. Lancet 2004, 364:900–909.
38. Ofori-Adjei D, Arhinful D: Effect of training on the clinical management of
malaria by medical assistants in Ghana. Soc Sci Med 1996, 42:1169–1176.
39. Ashley E, Stepniewska K, Lindega N, Annerberg A, Kham A, Brockman A,
Singhasivanon P, White N, Nosten F: How much fat is necessary to optimize
lumefantrine oral bioavailability? Trop Med Int Health 2007, 12:195–200.
40. Piola P, Fogg C, Bajumirwe F, Biraro S, Grandessa F, Ruzagira E, Babigumira J,
Kigozi I, Kiguli J, Kyomuhendo J, et al: Supervised versus unsupervised
intake of six-dose artemether-lumefanthrine for treatment of acute,
uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a
randomized trial. Lancet 2005, 365:1467–1473.
41. Zurovac D, Ndhlovu M, Rowe A, Hamer D, Thea D, Snow R: Treatment of
paediatric malaria during a period of drug transition to artemether-
lumefantrine in Zambia: cross sectional study. Br Med J 2005, 331:734.
42. DiMatteo M, Robert C, Joseph C: Enhancing Medication Adherence
Through Communication and Informed Collaborative Choice. Health
Commun 1994, 6(4):253–265.43. DiMatteo M, Hays R, Gritz E, Bastani R, Crane L, Elashoff R, Ganz P, Heber D,
McCarthy W, Marcus A: Patient adherence to cancer control regimens:
scale development and initial validation. Psychol Assess 1993, 5:102–112.
44. Simba D, Warsame W, Kimbute O, Kakoko D, Petzold M, Tomson G, Premji
Z, Gomes M: Factors Influencing Adherence to Referral Advice Following
Pre-Referral Treatment with Artesunate Suppositories in Children in
Rural Tanzania. Trop Med Int Health 2009, 14(7):775–783.
45. Thiede M: Information and access to health care: is there a role for trust?
Soc Sci Med 2005, 61:1452–1462.
46. Carpenter C: Conducting Qualitative Research in Physiotherapy: A
methodological example. Physiotherapy 1997, 83:547–552.
47. Todd J: Mixing qualitative and quantitative methods: triangulation in
action. Adm Sci Q 1979, 24:602–611.
doi:10.1186/1472-6963-12-146
Cite this article as: Simba and Kakoko: Primacy of effective
communication and its influence on adherence to artemether-
lumefantrine treatment for children under five years of age: a
qualitative study. BMC Health Services Research 2012 12:146.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
